Hydrocortisone

Myelodysplastic Syndrome

Andrew E. Place, MDSmall moleculePhase 3Active

BB

68/ 100

Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence: 61/ 100
Competitive Position: 81/ 100

Competitive context

295 Active assets in the Myelodysplastic Syndrome cohort.

Asset / Sponsor	Phase	Rating
Cyclophosphamide Sawa Ito, MD	Phase 4	BB
Busulphan Sawa Ito, MD	Phase 4	BB
Daunorubicin OHSU Knight Cancer Institute	Phase 3	BB
CYTARABINE The First Affiliated Hospital of Soochow University	Phase 4	BB
FILGRASTIM City of Hope Medical Center	Phase 4	BB

View all 50 →

Same molecule, other indications

Hydrocortisone is also rated in:

congenital adrenal hyperplasiaActive

A

Indicative · Phase 4

81 / 100

childhood acute lymphoblastic leukemiaActive

BB

Indicative · Phase 3

68 / 100

adrenocortical insufficiencyActive

BB

Indicative · Phase 3

68 / 100

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.